According to UBS, Max Healthcare is well-positioned to deliver both capacity expansion and earnings growth. The brokerage said that a CGHS price increase would provide a meaningful tailwind for the company.
According to UBS, Max Healthcare is well-positioned to deliver both capacity expansion and earnings growth. The brokerage said that a CGHS price increase would provide a meaningful tailwind for the company.